68 related articles for article (PubMed ID: 19711473)
21. [Partial re-screening of all negative smears. A method of quality control of pathology department concerning smear screening against cervix cancer].
Jensen ML; Dybdahl H; Svanholm H
Ugeskr Laeger; 2000 May; 162(21):3024-7. PubMed ID: 10850190
[TBL] [Abstract][Full Text] [Related]
22. Automated screening versus manual screening: a comparison of the ThinPrep imaging system and manual screening in a time study.
Schledermann D; Hyldebrandt T; Ejersbo D; Hoelund B
Diagn Cytopathol; 2007 Jun; 35(6):348-52. PubMed ID: 17497655
[TBL] [Abstract][Full Text] [Related]
23. A new era for the Pap test.
Holladay EB; Allen KA
JAAPA; 2001 Dec; 14(12):53-6. PubMed ID: 11824091
[TBL] [Abstract][Full Text] [Related]
24. Histopathology and medical laboratory scientific officers. Pathologists are responsible for diagnosis.
Wright DH
BMJ; 1994 Sep; 309(6957):803. PubMed ID: 7950576
[No Abstract] [Full Text] [Related]
25. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of 100% rapid rescreening of cervical smears.
Sood N; Singh V
Indian J Pathol Microbiol; 2009; 52(4):495-7. PubMed ID: 19805954
[TBL] [Abstract][Full Text] [Related]
27. Realities of diagnosing Helicobacter pylori infection in clinical practice: a case for non-invasive indirect methodologies.
Metz DC; Furth EE; Faigel DO; Kroser JA; Alavi A; Barrett DM; Montone K
Yale J Biol Med; 1998; 71(2):81-90. PubMed ID: 10378353
[TBL] [Abstract][Full Text] [Related]
28. Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice.
Santillan A; Govan L; Zahurak ML; Diaz-Montes TP; Giuntoli RL; Bristow RE
Gynecol Oncol; 2008 Jun; 109(3):388-93. PubMed ID: 18405946
[TBL] [Abstract][Full Text] [Related]
29. Does a zero error standard exist for the Papanicolaou smear? A pathologist's perspective.
Frable WJ
Arch Pathol Lab Med; 1997 Mar; 121(3):301-10. PubMed ID: 9111124
[TBL] [Abstract][Full Text] [Related]
30. Quality assurance in cytopathology. Recommendations and ongoing quality assurance activities of the American Society of Clinical Pathologists.
Bonfiglio TA
Acta Cytol; 1989; 33(4):431-3. PubMed ID: 2750429
[TBL] [Abstract][Full Text] [Related]
31. Routine prenatal and gynecologic care in prepaid group practice.
Hughey MJ
JAMA; 1986 Oct; 256(13):1775-7. PubMed ID: 3747088
[TBL] [Abstract][Full Text] [Related]
32. Laboratory reliability of the Papanicolaou smear.
Yobs AR; Swanson RA; Lamotte LC
Obstet Gynecol; 1985 Feb; 65(2):235-44. PubMed ID: 3969236
[TBL] [Abstract][Full Text] [Related]
33. Proficiency testing in laboratory medicine: uses and limitations.
Shahangian S
Arch Pathol Lab Med; 1998 Jan; 122(1):15-30. PubMed ID: 9448012
[TBL] [Abstract][Full Text] [Related]
34. Health Care Financing Administration/American Society for Cytotechnology inspections: government assessment of cytology laboratory practice under the regulations of the Clinical Laboratory Improvement Amendments of 1988.
Triol JH; Russell CD; Ashton PR
Arch Pathol Lab Med; 1997 Mar; 121(3):264-6. PubMed ID: 9111114
[TBL] [Abstract][Full Text] [Related]
35. [Personnel training for a population screening program for cervical carcinoma].
Branca M; Rossi E; Cedri C; Migliore G; Cedri S; Aldovini A; Leoncini L; Bonelli L; Montanari G; Navone R
Pathologica; 2001 Jun; 93(3):233-41. PubMed ID: 11433619
[No Abstract] [Full Text] [Related]
36. An economic model for comparing alternative policies for cervical cytologic smear screening.
Kaminsky FC; Burke RJ; Haberle KR; Mullins DL
Acta Cytol; 1995; 39(2):232-8. PubMed ID: 7887070
[TBL] [Abstract][Full Text] [Related]
37. [Use of clinical laboratory tests for early diagnosis (discussion)].
Watanabe K; Takahashi H; Furihata K; Kobayashi Y; Hiyama T
Nihon Naika Gakkai Zasshi; 2005 Dec; 94(12):2566-86. PubMed ID: 16419599
[No Abstract] [Full Text] [Related]
38. Standardization of terminology and reporting in gynecologic pathology: at last.
Stoler MH
Int J Gynecol Pathol; 2013 Jan; 32(1):1-2. PubMed ID: 23202793
[No Abstract] [Full Text] [Related]
39. Was Rodney Ledward a statistical outlier? Statistical method may be difficult to apply in clinical practice.
Cowling BJ; Hedley AJ
BMJ; 2005 Jun; 330(7505):1448; author reply 1448-9. PubMed ID: 15961828
[No Abstract] [Full Text] [Related]
40. Histopathology and medical laboratory scientific officers.
Fletcher S
BMJ; 1994 Dec; 309(6967):1513. PubMed ID: 7804067
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
